 Allena Pharmaceuticals, Inc., a Newton, MA-based biopharmaceutical company focused on developing and commercializing innovative non-systemic oral protein therapeutics to treat metabolic and orphan diseases, completed a 53m Series C financing. The round was led by Partner Fund Management with participation from new investors Fidelity Management Research Company and Wellington Management Company, and existing investors ... 